The three major stock indexes in the US stock market saw mixed gains and losses, and BioNTech's stock price fell after terminating clinical trials

According to BIT market data, at the opening of the US stock market, the Dow Jones Industrial Average rose 0.21%, the S&P 500 index rose 0.05%, and the Nasdaq fell 0.09%. BioNTech fell about 8.7% and announced the termination of phase 2 clinical trials for colorectal cancer.